Page last updated: 2024-09-04

jte 522 and Cancer of Endometrium

jte 522 has been researched along with Cancer of Endometrium in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, DD; Li, HL; Ren, XD; St-Tu, R; Zhang, HW; Zhong, L	1

Other Studies

1 other study(ies) available for jte 522 and Cancer of Endometrium

Article	Year
JTE-522, a selective COX-2 inhibitor, inhibits cell proliferation and induces apoptosis in RL95-2 cells. Acta pharmacologica Sinica, 2002, Volume: 23, Issue:7 Topics: Apoptosis; Benzenesulfonates; Caspase 3; Caspases; Cell Division; Cell Line, Tumor; Cyclooxygenase 2; Endometrial Neoplasms; Female; Humans; Isoenzymes; Membrane Proteins; Oxazoles; Prostaglandin-Endoperoxide Synthases; RNA, Messenger	2002

Article

Year

JTE-522, a selective COX-2 inhibitor, inhibits cell proliferation and induces apoptosis in RL95-2 cells.

Acta pharmacologica Sinica, 2002, Volume: 23, Issue:7

Topics: Apoptosis; Benzenesulfonates; Caspase 3; Caspases; Cell Division; Cell Line, Tumor; Cyclooxygenase 2; Endometrial Neoplasms; Female; Humans; Isoenzymes; Membrane Proteins; Oxazoles; Prostaglandin-Endoperoxide Synthases; RNA, Messenger

2002